21-Hydroxylase Deficiency future or investigational therapies

Jump to: navigation, search

21-Hydroxylase Deficiency Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating 21-Hydroxylase Deficiency from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Molecular Genetic Studies

Genotyping

Pelvic X Ray

CT

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Social Issues

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

21-Hydroxylase Deficiency future or investigational therapies On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of 21-Hydroxylase Deficiency future or investigational therapies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on 21-Hydroxylase Deficiency future or investigational therapies

CDC on 21-Hydroxylase Deficiency future or investigational therapies

21-Hydroxylase Deficiency future or investigational therapies in the news

Blogs on 21-Hydroxylase Deficiency future or investigational therapies</small>

Directions to Hospitals Treating 21-Hydroxylase Deficiency

Risk calculators and risk factors for 21-Hydroxylase Deficiency future or investigational therapies

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

References


Linked-in.jpg